183 related articles for article (PubMed ID: 34400904)
1. IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Fan Y; Wang X; Li Y
Int J Med Sci; 2021; 18(14):3342-3352. PubMed ID: 34400904
[No Abstract] [Full Text] [Related]
2. IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer.
Li L; Fei Y; Dong T; Song Y; Chen X; Zhang H; Zhou H; Liang M; Tang J
Int Immunopharmacol; 2024 May; 133():112093. PubMed ID: 38669947
[TBL] [Abstract][Full Text] [Related]
3. [Knockdown of interferon-γ inducible protein 30 (IFI30) inhibits the proliferation, invasion and migration of human glioma U251 cells by activating STAT1 and promotes their apoptosis].
Ye J; Xu W; Chen T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jan; 40(1):33-42. PubMed ID: 38246175
[TBL] [Abstract][Full Text] [Related]
4. Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Katchman BA; Ocal IT; Cunliffe HE; Chang YH; Hostetter G; Watanabe A; LoBello J; Lake DF
Breast Cancer Res; 2013 Mar; 15(2):R28. PubMed ID: 23536962
[TBL] [Abstract][Full Text] [Related]
5. Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression.
Huang Z; Li X; Xie T; Gu C; Ni K; Yin Q; Cao X; Zhang C
Cancer Res Treat; 2020 Oct; 52(4):1067-1083. PubMed ID: 32599985
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effect of the MAFG‑AS1/miR‑150‑5p/MYB axis on the proliferation and migration of breast cancer cells.
Jia H; Wu D; Zhang Z; Li S
Int J Oncol; 2021 Jan; 58(1):33-44. PubMed ID: 33367930
[TBL] [Abstract][Full Text] [Related]
7. Porcine IFI30 inhibits PRRSV proliferation and host cell apoptosis in vitro.
Guo J; Zhou M; Liu X; Pan Y; Yang R; Zhao Z; Sun B
Gene; 2018 Apr; 649():93-98. PubMed ID: 29366756
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
9. A Transcription Factor ZNF384, Regulated by LINC00265, Activates the Expression of IFI30 to Stimulate Malignant Progression in Glioma.
Yang J; Yang S; Cai J; Chen H; Sun L; Wang J; Hou G; Gu S; Ma J; Ge J
ACS Chem Neurosci; 2024 Jan; 15(2):290-299. PubMed ID: 38141017
[TBL] [Abstract][Full Text] [Related]
10. QSOX1 inhibits autophagic flux in breast cancer cells.
Poillet L; Pernodet N; Boyer-Guittaut M; Adami P; Borg C; Jouvenot M; Delage-Mourroux R; Despouy G
PLoS One; 2014; 9(1):e86641. PubMed ID: 24475161
[TBL] [Abstract][Full Text] [Related]
11. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
Yin Y; Cai J; Meng F; Sui C; Jiang Y
Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
[TBL] [Abstract][Full Text] [Related]
12. IFI30 expression is an independent unfavourable prognostic factor in glioma.
Liu X; Song C; Yang S; Ji Q; Chen F; Li W
J Cell Mol Med; 2020 Nov; 24(21):12433-12443. PubMed ID: 32969157
[TBL] [Abstract][Full Text] [Related]
13. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
14. NGS Evaluation of Colorectal Cancer Reveals Interferon Gamma Dependent Expression of Immune Checkpoint Genes and Identification of Novel IFNγ Induced Genes.
Xu L; Pelosof L; Wang R; McFarland HI; Wu WW; Phue JN; Lee CT; Shen RF; Juhl H; Wu LH; Alterovitz WL; Petricon E; Rosenberg AS
Front Immunol; 2020; 11():224. PubMed ID: 32265897
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
16. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of autophagy induced by PTEN loss promotes intrinsic breast cancer resistance to trastuzumab therapy.
Ning L; Guo-Chun Z; Sheng-Li A; Xue-Rui L; Kun W; Jian Z; Chong-Yang R; Ling-Zhu W; Hai-Tong L
Tumour Biol; 2016 Apr; 37(4):5445-54. PubMed ID: 26563373
[TBL] [Abstract][Full Text] [Related]
18. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
Yang Q; Ji G; Li J
Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
[TBL] [Abstract][Full Text] [Related]
19. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
20. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
